However, since miR-122-5p dysregulation impacts key immune pathways and promotes immune evasion, modulating its expression, alongside inhibiting the JAK/STAT pathway, might help to restore immune balance within the tumor microenvironment and improve the effectiveness of current treatment strategies. The gene discussed is SOAT1; the disease is neoplasm.